KRAS and colorectal carcinoma: Further, these new factors might be included in clinical risk scores, similar as reported for the KRAS status in the GAME score [70] and the KRAS/NRAS/BRAF status in the CERR score [71], which resulted in the refinement to predict recurrence after resection of CRC liver metastases.